Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Randox Toxicology is planning to introduce immunoassay solution for rapid detection of synthetic cannabinoids and designer drugs.
Subscribe to our email newsletter
The Drugs of Abuse Array V (DoA V) will enable detection of eight designer drugs and their metabolites within a single undivided specimen.
The panel targets Methcathinone, Mephedrone, MDPV (also known as bath salts), Benzylpiperazines, Phenylpiperazines, Mescaline, Salvinorin and other Synthetic Cannabinoids.
Randox launched an ELISA for the detection of synthetic cannabinoids in October 2011, which offers effective screening for designer drugs.